Skip to content

Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth

Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02923973
Enrollment
500
Registered
2016-10-05
Start date
2018-06-01
Completion date
2025-03-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth

Brief summary

Preterm birth (PTB) is the major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.Different strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of singleton gestations with both prior spontaneous PTB and TVU CL ≤25mm, and not in singletons without prior PTB, nor in multiple gestations. However, so far there are no level-1 data on the efficacy of TVU CL screening neither in low risk nor in high risk pregnancy Thus, the investigators aim to assess the efficacy of a policy of TVU CL screening in singleton pregnancy with prior spontaneous PTB

Interventions

Serial transvaginal ultrasound cervical length scan every week from 16 to 24 weeks

Sponsors

University of Pisa - Prof Paolo Mannella
CollaboratorUNKNOWN
Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* 18-50 years of age * Singleton gestations * Women with prior spontaneous preterm birth, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks

Exclusion criteria

* multiple gestation * Ruptured membranes or fetal structural or chromosomal abnormality at the time of randomization * Ballooning of membranes outside the cervix into the vagina at the time of randomization * Labor or cerclage in situ at the time of randomization

Design outcomes

Primary

MeasureTime frame
Preterm deliveryLess than 37 weeks gestation

Secondary

MeasureTime frameDescription
preterm birth ratesLess than 24, 28, 34 weeks gestation
Birth weightTime of delivery
Low birth weightTime of deliveryBirth weight \<2500g
Gestational age at deliveryTime of delivery
Composite adverse neonatal outcomeBetween birth and 28 days of ageIncludes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis and neonatal death
Admission to neonatal intensive care unitBetween birth and 28 days of age
Neonatal deathBetween birth and 28 days of age

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026